Genovese Burford & Brothers Wealth & Retirement Plan Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-1,291
| Closed | -$142K | – | 207 |
|
|
2018
Q2 | $142K | Buy |
1,291
+30
| +2% | +$3.3K | 0.05% | 98 |
|
|
2018
Q1 | $135K | Buy |
+1,261
| New | +$135K | 0.05% | 97 |
|
|
2017
Q4 | – | Sell |
-1,164
| Closed | -$129K | – | 330 |
|
|
2017
Q3 | $129K | Hold |
1,164
| – | – | 0.05% | 82 |
|
|
2017
Q2 | $120K | Hold |
1,164
| – | – | 0.05% | 87 |
|
|
2017
Q1 | $114K | Sell |
1,164
-375
| -24% | -$36.7K | 0.05% | 91 |
|
|
2016
Q4 | $137K | Buy |
1,539
+3
| +0.2% | +$267 | 0.04% | 91 |
|
|
2016
Q3 | $148K | Buy |
1,536
+321
| +26% | +$30.9K | 0.06% | 75 |
|
|
2016
Q2 | $104K | Sell |
1,215
-234
| -16% | -$20K | 0.04% | 96 |
|
|
2016
Q1 | $126K | Buy |
1,449
+234
| +19% | +$20.3K | 0.06% | 79 |
|
|
2015
Q4 | $137K | Buy |
+1,215
| New | +$137K | 0.07% | 72 |
|